{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:00:06Z","timestamp":1780923606403,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.trre.2026.101024","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:36:25Z","timestamp":1776900985000},"page":"101024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative waitlist mortality of autoimmune liver disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"40","author":[{"given":"Bachviet","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarpreet","family":"Powar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Montano-Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya","family":"Gulamhusein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daljeet","family":"Chahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2026.101024_bb0005","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4254\/wjh.v8.i28.1157","article-title":"Cirrhosis and autoimmune liver disease: current understanding","volume":"8","author":"Liberal","year":"2016","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.trre.2026.101024_bb0010","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2026.101024_bb0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.trre.2026.101024_bb0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.trre.2026.101024_bb0025","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/j.gastro.2024.01.049","article-title":"Immunopathogenesis of primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis: themes and concepts","volume":"166","author":"Trivedi","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trre.2026.101024_bb0030","article-title":"Prognostic models and autoimmune liver diseases","volume":"67","author":"D\u2019Amato","year":"2023","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.trre.2026.101024_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14479","article-title":"Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant","volume":"35","author":"Singal","year":"2021","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trre.2026.101024_bb0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/tri.13814","article-title":"Disease-specific waitlist outcomes in liver transplantation \u2013 a retrospective study","volume":"34","author":"Nagai","year":"2021","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trre.2026.101024_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14527","article-title":"Excess liver transplant waitlist mortality for patients with primary biliary cholangitis under MELD-Na allocation","volume":"36","author":"Zhou","year":"2022","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trre.2026.101024_bb0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/jcm9020319","article-title":"Mortality on the UNOS waitlist for patients with autoimmune liver disease","volume":"9","author":"Suri","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.trre.2026.101024_bb0055","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/jgh.16850","article-title":"Natural history and predictors of clinical outcomes in autoimmune liver diseases: a multicenter study","volume":"40","author":"Jayabalan","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.trre.2026.101024_bb0060","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2017.09.062","article-title":"Twenty-year comparative analysis of patients with autoimmune liver diseases on transplant waitlists","volume":"16","author":"Webb","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.trre.2026.101024_bb0065","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the american association for the study of liver diseases and the american society of transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2026.101024_bb0070","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMra2200923","article-title":"Liver transplantation","volume":"389","author":"Lucey","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trre.2026.101024_bb0075","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/LVT.0000000000000608","article-title":"Decompensated cirrhosis but low MELD-should we wait or refer for liver transplantation?","volume":"31","author":"Singh","year":"2025","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trre.2026.101024_bb0080","article-title":"Statement: an updated guideline for reporting systematic reviews","volume":"2021","author":"Page","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2026.101024_bb0085","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","article-title":"MOOSE reporting guidelines for meta-analyses of observational studies","volume":"156","author":"Brooke","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.trre.2026.101024_bb0090","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2024"},{"key":"10.1016\/j.trre.2026.101024_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ. Int."},{"key":"10.1016\/j.trre.2026.101024_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an r package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.trre.2026.101024_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100742","article-title":"Waitlist mortality in patients with autoimmune liver diseases","volume":"27","author":"Goyes","year":"2022","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.trre.2026.101024_bb0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00535-013-0782-5","article-title":"Waiting list mortality of patients with primary biliary cirrhosis in the japanese transplant allocation system","volume":"49","author":"Genda","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.trre.2026.101024_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/TP.0000000000002355","article-title":"Waiting list mortality and transplant rates for NASH cirrhosis when compared with cryptogenic, alcoholic, or AIH cirrhosis","volume":"103","author":"Thuluvath","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101024_bb0120","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1111\/liv.16017","article-title":"Evolving trends and outcomes on the US liver transplant waitlist of alcohol-associated hepatitis patients with very high MELD scores","volume":"44","author":"Tanaka","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.trre.2026.101024_bb0125","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1111\/liv.16100","article-title":"Waitlist and transplant outcomes in patients with metabolic dysfunction-associated steatotic liver disease and autoimmune hepatitis","volume":"44","author":"Medina-Morales","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.trre.2026.101024_bb0130","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.hpb.2018.03.013","article-title":"Waitlist mortality and post-transplant survival in patients with cholestatic liver disease \u2013 impact of changes in allocation policy","volume":"20","author":"Staufer","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.trre.2026.101024_bb0135","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/lt.22396","article-title":"Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era","volume":"17","author":"Goldberg","year":"2011","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trre.2026.101024_bb0140","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/tri.13097","article-title":"Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list-a retrospective study","volume":"31","author":"Goet","year":"2018","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trre.2026.101024_bb0145","article-title":"Prevalence and effect on prognosis of sarcopenia in patients with primary biliary cholangitis","volume":"11","author":"Yang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.trre.2026.101024_bb0150","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: The model for end-stage liver disease updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trre.2026.101024_bb0155","first-page":"62","article-title":"The development and appraisal of MELD 3.0 in liver diseases: good things never come easy","volume":"13","author":"Guo","year":"2025","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.trre.2026.101024_bb0160","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/HEP.0000000000001268","article-title":"Liver transplantation for cholestatic liver diseases: timing and disease recurrence","volume":"82","author":"Can\u00e7ado","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2026.101024_bb0165","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2026.101024_bb0170","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/liv.15829","article-title":"The evolving phenotype of autoimmune hepatitis across the millennium: The 40-year experience of a referral Centre in Italy","volume":"44","author":"Ferronato","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.trre.2026.101024_bb0175","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the american association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2026.101024_bb0180","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the american association for the study of liver diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2026.101024_bb0185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2022.01.022","article-title":"International autoimmune hepatitis group (IAIHG). Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation","volume":"77","author":"Montano-Loza","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.trre.2026.101024_bb0190","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/liv.15552","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis: a french nationwide study over 30years","volume":"43","author":"Chouik","year":"2023","journal-title":"Liver Int."}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:05:02Z","timestamp":1780920302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X26000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0955470X26000340"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2026.101024","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative waitlist mortality of autoimmune liver disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2026.101024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101024"}}